Epigenomic regulation of bile acid metabolism: emerging role of transcriptional cofactors.

Molecular and Cellular Endocrinology
Zachary SmithJongsook Kim Kemper

Abstract

The traditional role of bile acids is to simply facilitate absorption and digestion of lipid nutrients, but bile acids also act as endocrine signaling molecules that activate nuclear and membrane receptors to control integrative metabolism and energy balance. The mechanisms by which bile acid signals are integrated to regulate target genes are, however, largely unknown. Recently emerging evidence has shown that transcriptional cofactors sense metabolic changes and modulate gene transcription by mediating reversible epigenomic post-translational modifications (PTMs) of histones and chromatin remodeling. Importantly, targeting these epigenomic changes has been a successful approach for treating human diseases, especially cancer. Here, we review emerging roles of transcriptional cofactors in the epigenomic regulation of liver metabolism, especially focusing on bile acid metabolism. Targeting PTMs of histones and chromatin remodelers, together with the bile acid-activated receptors, may provide new therapeutic options for bile acid-related disease, such as cholestasis, obesity, diabetes, and entero-hepatic cancers.

References

Oct 6, 1998·Annual Review of Biochemistry·J L Workman, R E Kingston
Apr 8, 2000·Current Opinion in Genetics & Development·C L Peterson, J L Workman
Nov 21, 2000·Trends in Biochemical Sciences·J D Aalfs, R E Kingston
May 10, 2001·Current Opinion in Cell Biology·J C Rice, C D Allis
Aug 11, 2001·Science·T Jenuwein, C D Allis
Sep 5, 2001·Frontiers in Bioscience : a Journal and Virtual Library·A H HassanJ L Workman
Mar 7, 2003·Molecular Cell·Shilpa Kadam, Beverly M Emerson
Mar 29, 2003·Physiological Reviews·Michael Trauner, James L Boyer
Feb 18, 2004·Nature Reviews. Cancer·Charles W M Roberts, Stuart H Orkin
Oct 9, 2004·The Journal of Biological Chemistry·Meenakshisundaram AnanthanarayananMartin J Walsh
Nov 20, 2004·Nucleic Acids Research·Konstantinos Boulias, Iannis Talianidis
Nov 24, 2004·Nature Medicine·Antonio MoschettaDavid J Mangelsdorf
Apr 20, 2005·Biochemistry·Jérôme GobinetStéphan Jalaguier
Jun 24, 2005·The EMBO Journal·Konstantinos BouliasIannis Talianidis
Nov 9, 2005·Trends in Endocrinology and Metabolism : TEM·Ann BåvnerEckardt Treuter
Jan 7, 2006·Nature Reviews. Cancer·Saverio Minucci, Pier Giuseppe Pelicci
Mar 17, 2006·The EMBO Journal·Sander M HoutenJohan Auwerx
May 19, 2006·Expert Opinion on Therapeutic Targets·Shi-Ying Cai, James L Boyer
May 26, 2006·Nature Reviews. Molecular Cell Biology·Anjanabha SahaBradley R Cairns
Aug 15, 2006·FEBS Letters·Salvatore Modica, Antonio Moschetta
Aug 16, 2006·Trends in Biochemical Sciences·Florence Y LeeYanqiao Zhang
Sep 7, 2006·Nature Reviews. Drug Discovery·Jessica E BoldenRicky W Johnstone
Oct 31, 2006·Nature Medicine·Mihwa ChoiSteven A Kliewer
Feb 27, 2007·Cell·Tony Kouzarides
Apr 7, 2007·Trends in Pharmacological Sciences·Bertrand Cariou, Bart Staels
May 26, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jiansheng HuangLi Wang
Jun 26, 2007·Trends in Molecular Medicine·Stefano FiorucciLuca Santucci
Jun 30, 2007·Drugs·Bart Staels, Folkert Kuipers
Jul 27, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Nico MitroMaurizio Crestani
Sep 27, 2007·Proceedings of the National Academy of Sciences of the United States of America·Sabyasachi SanyalEckardt Treuter

❮ Previous
Next ❯

Citations

Jan 7, 2016·The Journal of Endocrinology·Libor Vítek, Martin Haluzík
Mar 27, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Frederick J Suchy, Meenakshisundaram Ananthanarayanan
Nov 5, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Masayuki NagahashiHuiping Zhou
Oct 14, 2014·Frontiers in Genetics·Steve Meaney
Sep 19, 2012·Biochimie·Steve Meaney
Dec 30, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Young-Chae KimJongsook Kim Kemper
Feb 5, 2021·Molecular and Cellular Endocrinology·Yonghe MaHaiming Cao
Mar 13, 2021·Biomarkers in Medicine·Alanah PietersMathieu Vinken

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.